title: Occurrence and prevention of contraction bands in Purkinje fibres, transitional cells and working myocardium during global ischaemia.
abstract: Contraction bands usually occur in the intramural working myocardium following post-ischaemic reperfusion. In the subendocardium, however, they are found during ischaemia. Thus, we ascertained the contraction states of Purkinje fibres, transitional cells, subendocardial and intramural parts of the working myocardium during 30 min global ischaemia at 25 degrees C. The effects with and without myocardial protection were compared. At the onset of pure ischaemia contraction bands are completely lacking in all cell types. During pure ischaemia contraction bands are found in all subendocardial cell types but not in the intramural working myocardium. A peak of pathological contraction states is found in the intramural working myocardium at the onset (0 min), in the subendocardial working myocardium at 10 min, in the transitional cells and Purkinje fibres at 30 min of pure ischaemia. Histidine-, tryptophan-, ketoglutarate-enriched (HTK) cardioplegia prevents contraction bands completely at the onset of ischaemia and prevents both contraction bands and pathological contraction states during ischaemia almost completely. Striking differences in the physiological contraction states are seen only in the working myocardium: HTK cardioplegia brings about dominance of relaxation during ischaemia. These findings may be due mainly to the effects of global ischaemia on the one hand and to catecholamines, calcium and oxygen on the other.
authors: Abteilung Vegetative Physiologie und Pathophysiologie, Zentrum Physiologie und Pathophysiologie, Göttingen, Federal Republic of Germany.
authors: P A
authors: PA
authors: Schnabel
authors: A
authors: A
authors: Schmiedl
authors: B
authors: B
authors: Ramsauer
authors: U
authors: U
authors: Bartels
authors: M M
authors: MM
authors: Gebhard
authors: J
authors: J
authors: Richter
authors: H J
authors: HJ
authors: Bretschneider
mesh_terms: D000818:Animals; D002314:Cardioplegic Solutions / Q000494:pharmacology; D003286:Contracture / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control; D003327:Coronary Disease / Q000150:complications* / Q000503:physiopathology; D004285:Dogs; D004699:Endocardium / Q000473:pathology; D006321:Heart / Q000503:physiopathology; D066298:In Vitro Techniques; D009206:Myocardium / Q000473:pathology*; D011690:Purkinje Fibers / Q000473:pathology; D012518:Sarcomeres / Q000648:ultrastructure
chemical_list: D002314:Cardioplegic Solutions